| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/2008 | EP1871370A2 Antibacterial compounds and uses thereof |
| 01/02/2008 | EP1871369A2 Dihydropyridine compounds and compositions for headaches |
| 01/02/2008 | EP1871368A2 Dihydropyridine compounds for neurodegenerative diseases and dementia |
| 01/02/2008 | EP1871367A2 Compounds for treating inflammatory and demyelinating diseases |
| 01/02/2008 | EP1871366A2 Drug delivery systems for treatment of diseases or conditions |
| 01/02/2008 | EP1871365A2 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases , pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| 01/02/2008 | EP1871364A1 Methods for treating or preventing acute myelogenous leukemia |
| 01/02/2008 | EP1871363A1 Combined-step process for pharmaceutical compositions |
| 01/02/2008 | EP1871361A2 Phospholipid-based pharmaceutical formulations and methods for producing and using same |
| 01/02/2008 | EP1871360A1 New anti-inflammatory compounds |
| 01/02/2008 | EP1871359A1 Delaying the ageing process and disorders caused by ageing |
| 01/02/2008 | EP1871358A1 Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists |
| 01/02/2008 | EP1871357A2 Substituted benzylamines as cyp2a inhibitors and uses thereof to treat nicotine dependence |
| 01/02/2008 | EP1871356A1 Dihydrobenzofuran derivatives and uses thereof |
| 01/02/2008 | EP1871355A1 New therapeutic combianations for the treatment or prevention of depression |
| 01/02/2008 | EP1871354A1 Treatment of pain |
| 01/02/2008 | EP1871353A2 Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy |
| 01/02/2008 | EP1871352A1 Treatment of cytokine dysregulation by using sn-2 gamma-linolenoyl, gamma-dihomolinolenoyl or arachidonoyl fatty acid glycerol monoesters |
| 01/02/2008 | EP1871351A2 Compositions and their uses directed to aceytl-coa carboxylases |
| 01/02/2008 | EP1871350A1 Methods of increasing natural killer cell activity for therapy |
| 01/02/2008 | EP1871349A1 Quaternary ammonium halides for treatment of infectious conditions |
| 01/02/2008 | EP1871347A1 Pharmaceutical composition |
| 01/02/2008 | EP1871346A1 Pharmaceutical composition containing sibutramine free base and manufacturing method thereof |
| 01/02/2008 | EP1871345A1 Nanoparticulate quinazoline derivative formulations |
| 01/02/2008 | EP1871342A2 A novel inter and intra multilamellar vesicular composition. |
| 01/02/2008 | EP1871183A1 Supplemental dietary composition for increasing muscle size and strength |
| 01/02/2008 | EP1871181A2 Nutritional supplement for hiv patients |
| 01/02/2008 | EP1871165A2 Method of treating schizophrenia prodrome |
| 01/02/2008 | EP1841421A4 The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency |
| 01/02/2008 | EP1784161B1 Controlled-release formulation comprising tamsulosin hydrochloride |
| 01/02/2008 | EP1761542B1 Octahydropyrrolo[3,4-c]pyrrole derivatives an their use as antiviral agents |
| 01/02/2008 | EP1753760B1 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
| 01/02/2008 | EP1750700B1 Liquid preparation for veterinary medicine, method for the production thereof, and use of the same |
| 01/02/2008 | EP1695094A4 Disintegratable films for diagnostic devices |
| 01/02/2008 | EP1656361B1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 01/02/2008 | EP1651201B1 Necrosis avid tracer agent |
| 01/02/2008 | EP1638492B1 Preoperative treatment of post operative pain |
| 01/02/2008 | EP1631267B1 Method for treating diseases using hsp90-inhibiting agents in combination with antimetabolites |
| 01/02/2008 | EP1553962A4 Combination chemotherapy with chlorotoxin |
| 01/02/2008 | EP1550675B1 Phospholipid derivative |
| 01/02/2008 | EP1549330B1 Pomolic acid for treating multidrug resistant tumours |
| 01/02/2008 | EP1539731B1 Novel compounds |
| 01/02/2008 | EP1539207A4 Treatment of cell proliferative disorders with chlorotoxin |
| 01/02/2008 | EP1537069B1 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 01/02/2008 | EP1526856B1 Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy |
| 01/02/2008 | EP1524983B1 Composition containing an androgenous 11-b-halogen steroid and a progestational hormone, and male contraceptive based on said composition |
| 01/02/2008 | EP1521573B1 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 01/02/2008 | EP1474422B1 R-(-)-1-¬2-(7-CHLOROBENZO-¬B -THIOPHEN-3-Yl-METHOXY)-2-(2,4-DICHLOROPHENYL)ETHYL -1H-IMIDAZOLE |
| 01/02/2008 | EP1471898B1 Lutein/zeaxanthin for glare protection |
| 01/02/2008 | EP1465663B1 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 01/02/2008 | EP1465614B1 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 01/02/2008 | EP1458743B1 Tetrahydrobenzfluorene derivatives |
| 01/02/2008 | EP1457492B1 Crystals of taxane derivative and process for their production |
| 01/02/2008 | EP1443942B1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonate, a cox-2 inhibitor and a taxol |
| 01/02/2008 | EP1435986B1 Igf-binding protein-derived peptide |
| 01/02/2008 | EP1423528B1 Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3' |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP1406859B1 Substituted 4-aminocyclohexanol derivatives |
| 01/02/2008 | EP1391198B1 Novel sphingolipid synthesis inhibitor |
| 01/02/2008 | EP1381376B1 Water-absorbent polymers and their use |
| 01/02/2008 | EP1372603A4 Topical application for treating toenail fungus |
| 01/02/2008 | EP1337241B1 Method of preparing microparticles for use in pharmaceutical compositions for inhalation |
| 01/02/2008 | EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 01/02/2008 | EP1331928B1 Particle formation methods and their products |
| 01/02/2008 | EP1272161B1 Lipid-based drug delivery systems against parasitic infections |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2008 | EP1263739B1 Crystalline salts of 7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl -(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 01/02/2008 | EP1263716B1 Amino acid derivatives as hiv aspartyl protease inhibitors |
| 01/02/2008 | EP1254130B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 01/02/2008 | EP1252307B1 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 01/02/2008 | EP1210082B1 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 01/02/2008 | EP1169036B1 Anti-viral uses of leflunomide products |
| 01/02/2008 | EP1129177B1 Avipox vector coding an hiv antigen and gamma-interferon |
| 01/02/2008 | EP1128827B1 Multilayer tablet comprising rosiglitazone |
| 01/02/2008 | EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/02/2008 | EP1121116B1 Sustained release pharmaceutical composition of fluvastatin |
| 01/02/2008 | EP1100870B1 Improvement of cardiac function by mesenchymal stem cell transplantation |
| 01/02/2008 | EP0830139B1 Modified myelin protein molecules |
| 01/02/2008 | CN200998435Y Tizanidine and the novel agent of the derivant thereof |
| 01/02/2008 | CN101099286A Method and installation means for installing an electrical machine |
| 01/02/2008 | CN101098894A High-molecular fucoidan, method of producing the same and cosmetic composition |
| 01/02/2008 | CN101098881A Macrolones - amino substituted quinolones |
| 01/02/2008 | CN101098877A Indoleamine 2,3-dioxygenase (ido) inhibitors |
| 01/02/2008 | CN101098876A Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
| 01/02/2008 | CN101098875A 无定形他克莫司及其制剂 Amorphous tacrolimus and its preparations |
| 01/02/2008 | CN101098873A 1,4 substituted pyrazolopyrimidines as kinase inhibitors |
| 01/02/2008 | CN101098872A Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 01/02/2008 | CN101098871A Novel spirotropane compounds and methods for the modulation of chemokine receptor activity |
| 01/02/2008 | CN101098870A Novel fused imidazole derivative |
| 01/02/2008 | CN101098869A 5-heteroaryl thiazoles and their use as p13k inhibitors |
| 01/02/2008 | CN101098868A Substituted indoles, compositions containing them, method for the production thereof and their use |
| 01/02/2008 | CN101098867A Substituted sulfoxide compound and its preparing method and application |
| 01/02/2008 | CN101098866A Heteroaromatic quinoline compounds and their use as pde10 inhibitors |
| 01/02/2008 | CN101098865A 1h-indole-3-carboxylic acid derivatives and their use as PPAR agonists |
| 01/02/2008 | CN101098862A New 3-phenylpropionic acid derivatives and their use as ppar-gamma rezeptor liganden |
| 01/02/2008 | CN101098861A Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators |
| 01/02/2008 | CN101098860A Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| 01/02/2008 | CN101098858A 吲唑磺酰胺衍生物 Indazole sulfonamide derivative |